Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1763950 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $2.60Day −6.81%Mkt cap $29M1Y −35.2%Off 52W high −54.7%Vol (1Y) 99.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,359 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest8.4% of sh out |
| Days to cover5.1d |
| 13F net flow (QoQ)−0.85% |
| Top-10 13F concentration92.2% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$15.9M |
| ROE−123.5% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−14.2% |
| 1Y−35.2% |
| 3Y−43.2% |
| 5Y−79.9% |
| Since incept. (ann.)−30.3% |
Total return through 2026-07-28 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)99.8% |
| Ann. volatility (3Y)97.8% |
| Sharpe (1Y)0.10 |
| Sharpe (3Y)0.31 |
| Max drawdown (1Y)−78.9% |
| Max drawdown (3Y)−89.5% |
| Beta (3Y vs SPY)5.15 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BIOS Capital Management, LP | 864,435 | $1M | 7.65% | −14.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | 332,079 | $454,948 | 2.94% | new |
| CM Management, LLC | 250,000 | $342,500 | 2.21% | +11.1% |
| RENAISSANCE TECHNOLOGIES LLC | 116,000 | $158,920 | 1.03% | +5.1% |
| GEODE CAPITAL MANAGEMENT, LLC | 111,646 | $152,984 | 0.99% | +15.4% |
| Westside Investment Management, Inc. | 50,050 | $68,571 | 0.44% | +39.4% |
| Voss Capital, LP | 50,000 | $68,500 | 0.44% | +0.0% |
| VANGUARD FIDUCIARY TRUST CO | 49,607 | $67,962 | 0.44% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$0.30 | — | — | — |
| 2025-09-30 | 2025-11-12 | −$0.39 | — | — | — |
| 2025-06-30 | 2025-08-13 | −$0.40 | — | — | — |
| 2025-03-31 | 2025-05-15 | −$0.42 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
